Stock Details
GILD is Gilead Sciences, Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 85.79$. Average daily volumn in 3 months 7.33M. Market cap 106.83B

Stock symbol : GILD. Exchange : NasdaqGS. Currency : USD
Lastest price : 85.67$. Total volume : 7.02M. Market state POST
Click reload if you want to check the lastest price on market!!!

Gilead Sciences, Inc. (GILD)
Last Price

Previous Close86.05
Day Range85.29-86.03
Bid85.48 x 900
Ask85.54 x 800
Average Volume7.33M
Market Cap106.83B
52 Week Range57.17-89.74
Trailing P/E23.54
Foward P/E11.74
Dividend (Yield %)3.49%
Ex-Dividend Date2023-03-14

Financial Details

According to Gilead Sciences, Inc.'s financial reports the company's revenue in 2022 were 27.28B an decrease(0%) over the years 2021 revenue that were of 27.3B. In 2022 the company's total earnings were 4.59B while total earnings in 2021 were 6.22B(-33.33%).

Loading ...


Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of li... ver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Market Cap:
Total Assets:
Total Cash:

News about "Gilead Sciences, Inc."


Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2022 Earnings Call Transcript

Source from : YAHOO!Finance - 5 days ago

Q4 2022 Earnings Call February 2, 2023 Operator: Good afternoon. Thank you for attending todayโ€™s Fourth Quarter and Full Year 2022 Gilead Sciences Earnings Conference Call. My name is Henna, and I ...See details»

Gilead Sciences Reaches Analyst Target Price

Source from : Nasdaq - 1 days ago

In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $86.12, changing hands for $86.36/share. When a stock reaches the target ...See details»

Gilead Sciences Inc. (NASDAQ: GILD) Stock Forecast: Bearish Views Expect -3.06 Percent Drop In 2023

Source from : stocksregister - 1 days ago

The trading price of Gilead Sciences Inc. (NASDAQ:GILD) closed higher on Monday, February 06, closing at $86.36, 2.20% higher than its previous close. Traders who pay close attention to intraday price ...See details»

gilead sciences inc.

Source from : Fox Business - 5 days ago

Pfizer and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG are racing to produce the first antiviral pill that people could take at early signs of the ...See details»


Gilead Sciences Inc. stock rises Tuesday, still underperforms market

Source from : MarketWatch - 8 days ago

Shares of Gilead Sciences Inc. inched 0.71% higher to $83.94 Tuesday, on what proved to be an all-around great trading session for the stock market, with ...See details»


Gilead Sciences Inc. stock rises Wednesday, outperforms market

Source from : MarketWatch - 14 days ago

Shares of Gilead Sciences Inc. GILD inched 0.06% higher to $84.07 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA ...See details»

Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend

Source from : Barron's - 6 days ago

About Gilead Sciences Pfizer on Tuesday laid out guidance for the 2023 fiscal year well below Wall Street consensus figures, tempering investor expectations ahead of what it expects to be a steep drop ...See details»

Gilead Sciences Inc. Q4 Profit Increases, beats estimates

Source from : Business Insider - 6 days ago

Gilead Sciences Inc. (GILD) reported earnings for its fourth quarter that increased from the same period last year and beat the ...See details»

Gilead Sciences Inc. (GILD) Just Got Our Attention

Source from : newsheater - 2 years ago

Gilead Sciences Inc. (NASDAQ:GILD) went up by 0.13% from its latest closing price compared to the recent 1-year high of $89.74. The companyโ€™s stock price has collected 0.87% of gains in the last five ...See details»

Gilead Sciences Inc. (GILD) Volatility Hits 1.79%: What Good Investors Need To Be Aware Of

Source from : stocksregister - 6 days ago

Gilead Sciences Inc. (NASDAQ:GILD) price on Friday, February 03, rose 3.89% above its previous dayโ€™s close as an upside momentum from buyers pushed the stockโ€™s value to $84.56. A look at the stockโ€™s ...See details»

Gilead Sciences, Inc. (NASDAQ:GILD) Delivered A Weaker ROE Than Its Industry

Source from : Yahoo Finance - 15 days ago

By way of learning-by-doing, we'll look at ROE to gain a better understanding of Gilead Sciences, Inc. (NASDAQ:GILD). ROE or return on equity is a useful tool to assess how effectively a company ...See details»

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Could Be 40% Below Their Intrinsic Value Estimate

Source from : Yahoo News - 1 month ago

Today we will run through one way of estimating the intrinsic value of Gilead Sciences, Inc. (NASDAQ:GILD) by taking the expected future cash flows and discounting them to today's value. One way to ...See details»

Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates

Source from : MSN - 6 days ago

Gilead Sciences (GILD) came out with quarterly earnings of $1.67 ... Another stock from the same industry, Reata Pharmaceuticals, Inc. (RETA), has yet to report results for the quarter ended December ...See details»

Gilead Sciences Again Named to Dow Jones Sustainability World Index

Source from : Stockhouse - 1 month ago

FOSTER CITY, CA / ACCESSWIRE / January 5, 2023 / Gilead Sciences, Inc. (Nasdaq:GILD) announced the company has once again been recognized as one of the most sustainable pharmaceutical companies ...See details»